INS and metabolic dysfunction-associated steatotic liver disease: Figure 4C identified the GO biological process terms, classified by –log10 (P-value). There was significant enrichment in organic acid metabolic process, oxoacid metabolic process, and carboxylic acid metabolic process. KEGG analysis identified significant enrichment pathways including non-alcoholic fatty liver disease, oxidative phosphorylation, and insulin resistance (Figure 4D). As shown in Supplementary Figure 4C, the KEGG network diagram identified 17 DEGs that Ribo-seq found enriched in the NAFLD pathway.